Results

Total Results: 2,463 records

Showing results for "testing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
    September 02, 2013 - Case reports are hypothesis generating rather than hypothesis testing. … Cohort and case-control studies are well suited for testing hypotheses of whether one intervention is … Cohort and case-control studies are well suited for testing hypotheses that one intervention is associated
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
    September 02, 2013 - Case reports are hypothesis generating rather than hypothesis testing. … Cohort and case-control studies are well suited for testing hypotheses of whether one intervention is … Cohort and case-control studies are well suited for testing hypotheses that one intervention is associated
  3. effectivehealthcare.ahrq.gov/health-topics/liver-function-tests
  4. effectivehealthcare.ahrq.gov/health-topics/blood-count-tests/
  5. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_educatingsessionparticipants.pdf
    May 18, 2012 - questioning by participants – Problem – may assume adversarial positions • Pretesting, cognitive testing
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
    February 01, 2012 - Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
    September 29, 2010 - Protocol Project Title: Antinuclear Antibody, Rheumatoid Factor, and Cyclic- Citrullinated Peptide Testing … No systematic reviews examining ANA for pediatric SLE or RF and CCP testing for JIA were identified … of symptoms KQ.3: What are the diagnostic performance characteristics of the ANA, RF, and CCP testing … Antinuclear antibody (ANA) testing. Pediatr Rev 2003;24:320-1. 4. Syed RH, Gilliam BE, Moore TL. … Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
  8. effectivehealthcare.ahrq.gov/health-topics/mental-health
    April 03, 2014 - September 30, 2012 Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing
  9. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - Largely because of widespread PSA testing, the lifetime risk of being detected with prostate cancer in … PSA testing detects more tumors, at an earlier stage, with smaller volume within each stage, and at an … Few enrolled men had prostate cancers waiting detected by PSA testing. … Prostate cancers not detected by PSA testing. … Only 5% of enrollees had prostate cancer detected by PSA testing.
  10. effectivehealthcare.ahrq.gov/products/sleep-apnea/research-protocol
    March 15, 2010 - Preoperative testing People with sleep apnea are at increased risk of surgical and anesthesia-related … KQ3: How does phased testing (screening tests or battery followed by full test) compare to full testing … Key question 3 evaluates phased testing. We will not otherwise review the order of testing. … covered in the systematic review (in background material / introduction of report) KQ 2 Formal testing … For program testing and training purposes, we will manually screen 1000 abstracts, each twice.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
    July 01, 2012 - medical test review are: to identify and synthesize evidence to evaluate the impacts of alternative testing … The analytic framework was of limited value, as several possible relevant testing strategies were not … The testing strategy in the lower portion of the decision tree entails performing biopsy in all patients … Noninvasive carotid artery testing. A meta- analytic review. … HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
    July 01, 2012 - standard tools for grading evidence were designed for questions about treatment rather than diagnostic testing … The degree of harms from false positives depends on the invasiveness of further testing or treatment … versus not testing is a toss-up—where net benefits are equivalent to net harms. … The impact of plausible unmeasured confounders may be relevant to testing strategies that predict outcomes … Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
    January 08, 2013 - CER #50: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children Original release date: March, 2012 Surveillance Report: March, 2013 Key Findings: - All conclusions from the original CER are up to date. Summary Decisio…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
    March 01, 2012 - 1 Comparative Effectiveness Review Number 50 Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children Executive Summary Background Musculoskeletal (MSK) pain is common in children and adolescents, with an estimated prevalence rangin…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - Additionally, owing to the overlapping findings of the C. difficile testing chapter in MHS III, our … rapid response also subsumes the C. difficile surveillance and testing topics as they relate to ASC … difficile testing in 2017 has led to an acceleration in publications evaluating C. difficile testing … Holding firm: Use of clinical correlation to improve Clostridioides difficile testing. … , time to testing, and mandatory reporting.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
    March 07, 2012 - We have indicated that IIF is the gold standard for ANA testing and have referenced the ACR consensus … I am not sure that the authors have a clear understanding of ANA testing. … the utility of ANA testing in children with MSK pain. … We have reworded the introduction to address changes in ANA testing (p 2-3). … The authors do not address the issue of changes in ANA testing at all.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
    December 01, 2015 - Rationale for Evidence Review Accurate testing of patients presenting with symptoms consistent with … For the populations listed under Key Question 1a, what is the effect of alternative testing strategies … What factors modify the comparative effectiveness of testing for patients with RLQ pain and suspected … It is likely that the lack of separation between the training and testing datasets led to optimistic … Adverse Events of Testing Information on harms was often incomplete and poorly reported.
  18. effectivehealthcare.ahrq.gov/health-topics/skin-conditions
    December 08, 2017 - Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin Systematic Review December 8, 2017 Technical Brief: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques Research Protocol Archived August 23, 2010 Systematic Review of Treatments f…
  19. effectivehealthcare.ahrq.gov/health-topics/breast-diseases
    February 13, 2012 - Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review Systematic Review Archived February 13, 2012 Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Systematic Review Archived February 9, 2006 Data Points #14: Use of endocrine t…
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
    July 01, 2012 - what it measures, how it is done, how clinical specimens are obtained, processed, and stored for testing … What is the applicable testing scenario? … Cost effectiveness: Do the improvements in patient outcomes justify the additional costs of testing … Were the subjects somehow referred or selected for testing? What was the testing scenario? 3.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: